Navigation Links
Precision Optics Corporation Announces $1 Million Order for Microprecision™ Based Endoscopes

GARDNER, Mass., April 19, 2012 /PRNewswire/ -- Precision Optics Corporation, Inc. (OTCQB:PEYE) (the "Company") today announced that it has accepted a customer order for $1,032,000 for delivery of endoscopes.  The purchase order is contingent upon successful completion of validation testing of prototype units, and execution of a mutually acceptable supply agreement specifying, among other items, the delivery schedule.

The endoscopes ordered represent state-of-the-art medical devices with optical and mechanical specifications that are among the most challenging in the industry.  They rely heavily on the Company's proprietary Microprecision™ technology for fabrication and assembly of lenses and prisms with sizes less than 1 mm.

Commenting on the order, Joseph Forkey, Company President and CEO, said, "We have made the development of our Microprecision™ technology a priority over the last few years and are pleased at the recognition in the marketplace of the potential for these new capabilities.  We believe many additional applications for our Microprecision™ technology exist, especially in medical devices where the highest quality optical performance coupled with the smallest possible size can produce medical benefits for patients and opportunities for new procedures for our customers.  We look forward to satisfying the validation requirements of this order and to beginning production as soon as possible."

About Precision Optics Corporation 

Precision Optics Corporation has been a leading developer and manufacturer of advanced optical instruments since 1982.  The Company designs and produces next generation medical instruments, Microprecision™ micro-optics with characteristic dimensions less than 1 millimeter, and other advanced optical systems based on the Company's state-of-the-art optical technologies. The Company's innovative medical instrumentation line includes Lenslock™ laparoscopes, arthroscopes, and sinuscopes, as well as endocouplers and a world-class product line of 3D endoscopes for use in minimally invasive surgical procedures. The Company's website is Investors can find Real-Time quotes and market information for the Company on

This news release contains forward-looking statements that involve risks and uncertainties.  You should not place undue reliance on these forward-looking statements.  The Company's actual results could differ materially from those anticipated in the forward-looking statements for many reasons.  Such risks are described in reports The Company files with the Securities and Exchange Commission including The Company's annual report on Form 10-K.  Although the Company believes the expectations reflected in the forward-looking statements are reasonable, they relate only to events as of the date on which the statements are made.  The Company does not intend to update any of the forward-looking statements after the date of this new release to conform these statements to actual results or to changes in its expectations, except as required by law. 

SOURCE Precision Optics Corporation, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Life Technologies Launches GeneArt® Precision TALs
2. Precision Antibody Expands Antibody Characterization Services
3. Precision Therapeutics Enhances Their Straightforward Approach to Personalizing Cancer Care
4. Cogmedix Provides High-Precision Subassembly for LensAR Revolutionary Refractive Laser
5. Boston Scientific Receives FDA Approval for New Infinion™ 16 Percutaneous Lead for Precision Plus™ Spinal Cord Stimulator System
6. TIs new MSP430™ microcontrollers enable more performance and higher precision in home automation, industrial and portable medical applications
7. Upgraded ACCF/ AHA/ SCAI Guidelines Reinforce Benefits of Volcanos Precision Guided Therapy Technologies
8. TechPrecision Corporations WCMC Division Adds Second Sapphire Customer
9. Vapotherm® Announces FDA Clearance for Precision Flow® Heliox System
10. FDA Awards Precision Antibody Contract to Develop Monoclonal Antibodies for Influenza Vaccine Potency Assays
11. Precision Therapeutics Named on Inc. 500
Post Your Comments:
(Date:6/24/2016)... , June 24, 2016  Collagen Matrix, ... design, development and manufacturing of collagen and mineral ... announced today that Bill Messer has ... Marketing to further leverage the growing portfolio of ... devices. Bill joins the Collagen Matrix ...
(Date:6/24/2016)... Va. , June 24, 2016 The ... set of recommendations that would allow biopharmaceutical ... (HCEI) with entities that make formulary and coverage decisions, ... the "value" of new medicines. The recommendations ... does not appear on the drug label, a prohibition ...
(Date:6/24/2016)... 24, 2016   Pulmatrix, Inc ., (NASDAQ: ... inhaled drugs, announced today that it was added to ... its comprehensive set of U.S. and global equity ... an important milestone for Pulmatrix," said Chief Executive Officer ... of our progress in developing drugs for crucial unmet ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... 25, 2016 , ... Austin residents seeking Mohs surgery services, can now turn ... to Dr. Russell Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization ... selective fellowship in Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction ...
(Date:6/25/2016)... Beach, CA (PRWEB) , ... June 25, 2016 , ... ... UCLA with Magna Cum Laude and his M.D from the David Geffen School of ... Diego and returned to Los Angeles to complete his fellowship in hematology/oncology at the ...
(Date:6/24/2016)... ... ... A recent article published June 14 on E Online details ... to state that individuals are now more comfortable seeking to undergo not only the ... and cheek reduction. The Los Angeles area medical group, Beverly Hills Physicians (BHP) notes ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... and Scientific Sessions in Dallas that it will receive two significant new grants ... grants came as PHA marked its 25th anniversary by recognizing patients, medical professionals ...
(Date:6/24/2016)... ... ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for ... $12 an hour by 2020 and then adjusting it yearly to increase at the same ... wage, assure the wage floor does not erode again, and make future increases more predictable. ...
Breaking Medicine News(10 mins):